Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.03B |
| 2 |
Tesla
TSLA
|
+$1.19B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$840M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$589M |
| 5 |
Pinduoduo
PDD
|
+$576M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.43B |
| 2 |
Apple
AAPL
|
+$1.43B |
| 3 |
Amazon
AMZN
|
+$1.25B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.22B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$923M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 10.21% |
| 3 | Financials | 9.5% |
| 4 | Consumer Discretionary | 7.6% |
| 5 | Communication Services | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Arbutus Biopharma
ABUS
$915M
| $1.96M | ﹤0.01% |
1,938,329
+1,852,238
| +2,151% | +$5.01M |
|
3277
First Interstate BancSystem
FIBK
$3.58B
| $1.96M | ﹤0.01% |
67,909
-67,342
| -50% | -$2.42M |
|
3278
Bank of N.T. Butterfield & Son
NTB
$2.45B
| $1.96M | ﹤0.01% |
114,873
+22,475
| +24% | +$660K |
|
3279
PUT
Regeneron Pharmaceuticals
REGN
$80.8B
| $1.95M | ﹤0.01% |
+4,000
| New | +$1.65M |
|
|
EBIX
3280
DELISTED
Ebix Inc
EBIX
| $1.95M | ﹤0.01% |
128,306
+50,421
| +65% | +$1.44M |
|
|
NEOS
3281
DELISTED
Neos Therapeutics, Inc
NEOS
| $1.94M | ﹤0.01% |
2,592,072
+32,698
| +1% | +$44.9K |
|
|
HSKA
3282
DELISTED
Heska Corp
HSKA
| $1.94M | ﹤0.01% |
35,098
+19,705
| +128% | +$1.78M |
|
3283
Passage Bio
PASG
$14.1M
| $1.94M | ﹤0.01% |
+6,160
| New | +$1.93M |
|
|
MFGP
3284
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $1.94M | ﹤0.01% |
382,358
+192,480
| +101% | +$1.95M |
|
3285
National Healthcare
NHC
$3.38B
| $1.94M | ﹤0.01% |
26,986
+1,032
| +4% | +$81.6K |
|
3286
Bank of Marin Bancorp
BMRC
$459M
| $1.93M | ﹤0.01% |
64,466
+15,979
| +33% | +$630K |
|
3287
Invesco BuyBack Achievers ETF
PKW
$1.76B
| $1.93M | ﹤0.01% |
39,890
| – | – |
|
3288
CALL
Live Nation Entertainment
LYV
$42.1B
| $1.93M | ﹤0.01% |
+42,500
| New | +$2.63M |
|
3289
LeMaitre Vascular
LMAT
$1.86B
| $1.93M | ﹤0.01% |
77,391
-5,326
| -6% | -$164K |
|
|
TBRG
3290
DELISTED
TruBridge
TBRG
| $1.92M | ﹤0.01% |
86,397
-9,610
| -10% | -$247K |
|
3291
PUT
Appian
APPN
$2.48B
| $1.92M | ﹤0.01% |
+47,700
| New | +$2.22M |
|
3292
Assembly Biosciences
ASMB
$529M
| $1.91M | ﹤0.01% |
10,706
+6,228
| +139% | +$1.34M |
|
|
CLDR
3293
CALL
DELISTED
Cloudera, Inc.
CLDR
| $1.9M | ﹤0.01% |
241,800
+209,400
| +646% | +$2.04M |
|
3294
PUT
DaVita
DVA
$11.7B
| $1.9M | ﹤0.01% |
25,000
| – | – |
|
3295
PDF Solutions
PDFS
$2.07B
| $1.9M | ﹤0.01% |
162,277
+47,764
| +42% | +$706K |
|
3296
CALL
VanEck Oil Services ETF
OIH
$1.84B
| $1.89M | ﹤0.01% |
23,500
-20,340
| -46% | -$3.79M |
|
3297
QuinStreet
QNST
$1.21B
| $1.89M | ﹤0.01% |
234,295
+41,734
| +22% | +$514K |
|
|
MEET
3298
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $1.88M | ﹤0.01% |
320,589
+72,796
| +29% | +$415K |
|
|
TPC
3299
Tutor Perini Cor
TPC
$5.21B
| $1.88M | ﹤0.01% |
279,646
-140,105
| -33% | -$1.5M |
|
|
SRNE
3300
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $1.88M | ﹤0.01% |
1,020,866
+811,409
| +387% | +$2.34M |
|
Similar funds
Goldman Sachs's Q1 2020 Portfolio in Review
As of Q1 2020, Goldman Sachs held 5,784 positions worth $284B, down 28% from $393B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs withdrew a net $27.9B in Q1 2020, closing 606 positions and reducing 2,198 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $731M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Vertiv worth $138M.
- Goldman Sachs's largest Q1 2020 buy was Vertiv: 15,967,049 shares worth $138M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $4.03B increase.
- Goldman Sachs's biggest Q1 2020 reduction was Microsoft, cutting an estimated $2.43B.
- Goldman Sachs fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $731M.
- Goldman Sachs's ten largest holdings make up 18% of its $284B portfolio in Q1 2020.
- Goldman Sachs opened 600 new positions and closed 606 in Q1 2020.
- Goldman Sachs's portfolio value fell 28% quarter-over-quarter to $284B.
Based on Goldman Sachs's 13F filing for Q1 2020, filed 15 May 2020.